Consultancy shares, page-10

I been watching UNS since 2008 (i am not a current holder) before the big move to the US and watched the price go from 22c to $1.78.... i even held a few times,
My biggest issue i had back then is still here now...... Transparency,

Todays Ann is further disappointment and enforces my point, disregard all the so called "contracts with large pharmaceuticals" and lack of detail for any holder/potential holder to evaluate.
To hear AS is now getting consultancy fee is shares with ZERO detail is a kick in the guts,
In true UNS form...... the detail is left out,
No term indicated, No figure or Package.... for all we know it could be (for example) $3mil/yr.

Its a shame because i do believe the unilife range of products IS a game changer but managed poorly and without transparency.

GLTA,
Time 4 talk on this 1 has come on gone.....transparency and communications to holders been weakest point.